Financials data is unavailable for this security.
View more
Year on year Medrx Co Ltd had revenues fall -50.35% from 59.48m to 29.53m, though the company grew net income from a loss of 1.11bn to a smaller loss of 932.90m.
| Gross margin | 0.10% |
|---|---|
| Net profit margin | -227.78% |
| Operating margin | -243.43% |
| Return on assets | -23.36% |
|---|---|
| Return on equity | -24.21% |
| Return on investment | -24.06% |
More ▼
Cash flow in JPYView more
In 2023, Medrx Co Ltd increased its cash reserves by 73.11%, or 726.70m. Cash Flow from Financing totalled 1.64bn or 5,551.20% of revenues. In addition the company used 913.80m for operations while cash used for investing totalled 759.00k.
| Cash flow per share | -7.01 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 55.41 |
|---|---|
| Tangible book value per share | 55.41 |
More ▼
Balance sheet in JPYView more
| Current ratio | 27.91 |
|---|---|
| Quick ratio | 27.76 |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
